Skip to content
PaperFren

Depression treatment

Does smoking track with depression in US adults?

Wu Z, Yue Q, Zhao Z, et al. · Frontiers in public health · 2023

Open access · cc by · source: Europe PMC

In NHANES 2005–2018, daily smokers had ~2.4× the odds of PHQ-9 depression vs never smokers; longer cessation tracked lower odds.

How this study connects

Role on claims

Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.

  • SupportsSmoking and depressionconcept

    Daily smoking shows the highest depression odds vs never smokers in NHANES.

    In 30,524 US adults, daily smokers had OR 2.37 for PHQ-9–defined depressive symptoms vs never smokers; longer cessation tracked lower odds.

    Evidence for the claim as stated.

  • QualifiesSmoking and depressionconcept

    Cessation can be supported with ecological momentary interventions.

    An EMI smoking-cessation evaluation tests delivering support in daily life—intervention evidence, not the same as the NHANES association estimate.

    Scope note — intervention study ≠ cross-sectional OR for depression

    Limits the claim's scope: a different population, assay, or outcome.

  • QualifiesSmoking and depressionconcept

    Tobacco smoking associates with many cardiovascular disease subtypes.

    Large-scale tobacco analyses link smoking to broad cardiovascular subtype risk—downstream disease burden beyond mood symptoms.

    Scope note — CV subtype risk ≠ depression PHQ-9 odds

    Limits the claim's scope: a different population, assay, or outcome.

  • SupportsSmoking and depressionconcept

    Association ORs for depression, cessation trial/intervention results, and CV disease risk from tobacco should not be treated as one causal chain without designs that can test directionality.

    Evidence for the claim as stated.

Open questions

Tensions this paper is part of

From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.

Study at a glance

Design
Cross-sectional — NHANES 2005–2018 smoking status/volume/cessation vs PHQ-9 depression
N
N=30524 · Adults ≥20 in final smoking-status analysis after exclusions
Population
US adults in NHANES with smoking and depression measures
Outcome
Clinically relevant depressive symptoms (PHQ-9 ≥10) by smoking patterns

Structured fields used in claim comparison tables when every cited study has a complete layer.

Inspect source passages

Does smoking track with depression in US adults?

These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.

Daily smokers OR 2.37 for depression vs never smokers.

Daily smokers had the highest risk of depression (OR = 2.37, 95% CI: 2.05–2.75).

Previous OR 1.25; occasional OR 1.84 vs never smokers.

Previous smokers [odds ratio (OR) = 1.25, 95% confidence interval (CI): 1.05–1.48] and occasional smokers (OR = 1.84, 95% CI: 1.39–2.45) were associated with a higher risk of depression compared with never smokers.
Read passages in the original paper

Key findings

Previous (OR 1.25), occasional (OR 1.84), and daily smokers (OR 2.37) had higher depression odds than never smokers. Higher daily volume associated with higher odds (OR 1.65 trend); longer cessation associated with lower odds (OR 0.55 trend).

Methodology

Analyzed adults ≥20 from NHANES 2005–2018, classifying smoking status, daily volume, and cessation duration against PHQ-9 ≥10 using multivariable logistic regression.

Limitations

Cross-sectional data cannot establish whether smoking causes depression or depressed people smoke more; residual confounding remains.

Related papers in this topic

Same topic cluster — not a recommendation engine.